Passa al contenuto
Merck
Tutte le immagini(2)

Documenti fondamentali

HLINJMAG-75K

Millipore

MILLIPLEX® Human Liver Injury Magnetic Bead Panel - Toxicity Multiplex Assay

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali


About This Item

Codice UNSPSC:
12161503
eCl@ss:
32161000
NACRES:
NA.47

Descrizione

The analytes available for this multiplex kit are: Liver-type arginase 1 (ARG1), α-glutathianone S-transferase (GSTα), malate dehydrogenase 1 (MDH1), sorbitol dehydrogenase (SDH), and 5′-Nucleotidase (5′-NT/CD73).

Livello qualitativo

100
200

Reattività contro le specie

human

Produttore/marchio commerciale

Milliplex®

assay range

accuracy: 106-123%
standard curve range: 14-10,000 pg/mL
(GSTα)

standard curve range: 41-30,000 pg/mL
(5′-NT/CD73)

standard curve range: 549-400,000 pg/mL
(SDH)

standard curve range: 69-50,000 pg/mL
(ARG1)

standard curve range: 69-50,000 pg/mL
(MDH1)

tecniche

multiplexing: suitable

Metodo di rivelazione

fluorometric (Luminex xMAP)

Condizioni di spedizione

ambient

Descrizione generale

Drug toxicity is the leading cause of acute liver failure in the United States. Patients with liver damage generally display elevated amounts of specific liver proteins in serum; these proteins can serve as biomarkers of drug-related liver toxicity. Monitoring these biomarkers can greatly help clinicians avoid drug-induced liver failure. Performing laboratory tests to characterize the side effects of potential therapeutics is an essential part of drug development. The search for sensitive, organ-specific toxicity biomarkers is complemented by the development of novel assays to measure these critical analytes. Liver-Type Arginase 1 (ARG1), α-glutathione Stransferase (GSTα), Malate dehydrogenase 1 (MDH1) and Sorbitol Dehydrogenase (SDH) are biomarkers listed in the Predictive Safety Testing Consortium (PSTC) project pipeline which have a strong translational role in drug safety testing. 5′-Nucleotidase/CD73 (5′-NT) is a traditional biomarker recognized by both the Food and Drug Administration (FDA) and its European counterpart, the European Medicines Agency (EMA).

The MILLIPLEX® Human Liver Injury Panel contains all the components necessary to simultaneous quantify the following 5 analytes in serum and plasma samples:
• Liver-Type Arginase 1 (ARG1)*
• Malate dehydrogenase 1 (MDH1)*
• α-glutathione S-transferase (GSTα)*
• Sorbitol Dehydrogenase (SDH)*
• 5′-Nucleotidase/CD73 (5′-NT)

*ARG1, GSTα, and SDH are biomarkers listed in the Predictive Safety Testing Consortium (PSTC) project pipeline which have a strong translational role in drug safety testing.

The MILLIPLEX® portfolio offers the broadest selection of analytes across a wide range of disease states and species. Once the analytes of interest have been identified, you can rely on the quality that we build into each kit to produce results you can trust. In addition to the assay characteristics listed in the protocol, other performance criteria evaluated during the validation process include: cross-reactivity, dilution linearity, kit stability, and sample behavior (e.g. detectability and stability).

Panel Type: Toxicity

Specificità

Cross Reactivty
There was no or negligible cross-reactivity between the antibodies for an analyte and any of the other analytes within a panel.

Applicazioni

  • Analytes: ARG1, GSTα, SDH 5′-NT/CD73, Malate dehydrogenase 1 (MDH1)
  • Recommended Sample type: serum, plasma, and tissue culture supernatants
  • Recommended Sample dilution: 1:5 serum or plasma samples. Tissue culture supernatants may require dilution as well.
  • Assay Run Time: One day or Overnight
  • Research Category: Toxicity

Caratteristiche e vantaggi

Design your multiplex kit by choosing available analytes within this panel.

Confezionamento

Everything you need in a single kit.

Stoccaggio e stabilità

Recommended storage for kit components is 2 - 8°C.

Altre note

Please contact Technical Service for linearity of dilution.
Sensitivity: Please see kit protocol for individual assay sensitivities.

Note legali

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

Esclusione di responsabilità

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Pittogrammi

Skull and crossbonesEnvironment

Avvertenze

Danger

Indicazioni di pericolo

Classi di pericolo

Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Skin Sens. 1

Codice della classe di stoccaggio

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe di pericolosità dell'acqua (WGK)

WGK 3


Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.